The European Medicines Agency (EMA) on Monday released a plan detailing how it would respond to a cross-border emerging health threat.
According to EMA, the plan is based on its 2006 pandemic influenza plan and has been updated based on experience gained during recent disease outbreaks such as the 2009 H1N1 influenza pandemic and the 2014-2016 Ebola virus outbreak.
While EMA says that pandemic influenza and other biological health threats are the “most likely cause of an emerging health threat,” the plan also covers other health threats of chemical, environmental and unknown origins.
Specifically, the 15-page plan details the roles and responsibilities of EMA staff and scientific committees during a health emergency and covers procedural matters to expedite the development and authorization of products to prevent or treat an emerging health threat.
“EMA’s role is to provide the best possible scientific and regulatory advice to support member states in taking the necessary public health decisions,” EMA says…